2.12
Precedente Chiudi:
$2.295
Aprire:
$2.22
Volume 24 ore:
83,278
Relative Volume:
0.07
Capitalizzazione di mercato:
$14.48M
Reddito:
-
Utile/perdita netta:
$-19.54M
Rapporto P/E:
-1.6219
EPS:
-1.3071
Flusso di cassa netto:
$-21.18M
1 W Prestazione:
-3.64%
1M Prestazione:
+221.70%
6M Prestazione:
+214.07%
1 anno Prestazione:
-39.26%
Calcimedica Inc Stock (CALC) Company Profile
Nome
Calcimedica Inc
Settore
Industria
Telefono
858-952-5500
Indirizzo
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CALC
Calcimedica Inc
|
2.12 | 15.67M | 0 | -19.54M | -21.18M | -1.3071 |
|
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc Borsa (CALC) Ultime notizie
Investors can meet CalciMedica on Sept. 15 - Stock Titan
CalciMedica, Inc. (CALC) Stock Price & News - Syfe
CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk - TipRanks
CalciMedica (NASDAQ: CALC) fixes one Nasdaq warning but faces a $1 price deadline - Stock Titan
Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move - GuruFocus
CALC Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 7.84%Tax Rate Impact - vinanet.vn
CalciMedica To Carry Out 1-for-5 Reverse Stock Split On August 31st, 2026 - Moomoo
CalciMedica executes 1-for-5 reverse stock split By Investing.com - Investing.com South Africa
CalciMedica executes 1-for-5 reverse stock split - Investing.com
CalciMedica Announces One-for-Five Reverse Stock Split - marketscreener.com
CalciMedica (CALC) Quarter in Focus: The Available Earnings Metric Delivers a Beat; Closing Move: Shares Move Higher 5.68% for the Current SessionROA Comparison - dars.gov.et
Stonepine takes CalciMedica (CALC) stake via capped warrants - Stock Titan
Alafi Capital updates CalciMedica (NASDAQ: CALC) stake after multimillion-warrant grant - stocktitan.net
CalciMedica (CALC) grants director 10,000 stock options through 2036 - Stock Titan
CalciMedica (NASDAQ: CALC) awards director 10,000 options at $0.61 - Stock Titan
CalciMedica (CALC) grants director 10,000 stock options at $0.61 - Stock Titan
CalciMedica (CALC) director granted 2.9M-share warrants with 9.99% cap - Stock Titan
CalciMedica (NASDAQ: CALC) grants FDA-linked warrants capped at 19.99% stake - Stock Titan
CalciMedica (NASDAQ: CALC) CEO granted new stock warrants - Stock Titan
CalciMedica (NASDAQ: CALC) has 9.99% holder blocked from using more warrants - Stock Titan
CalciMedica (CALC) Financial Update: EPS Lands Above Forecast in the Current Update; The Stock Ends Down 4.88% in the Current UpdateProfit Inflection Point - vinanet.vn
ARMISTICE CAPITAL, LLC Acquires Significant Stake in CalciMedica Inc (CALC) - GuruFocus
CalciMedica Shareholders Approve Reverse Stock Split - Minichart
CalciMedica Shareholders Approve Key Equity and Governance Changes - TipRanks
CalciMedica (NASDAQ: CALC) holders back reverse split and warrant deals - Stock Titan
Guggenheim initiates CalciMedica stock with buy rating on drug potential - Investing.com
Guggenheim initiates CalciMedica stock coverage with buy rating By Investing.com - Investing.com India
CalciMedica (CALC) Edges Higher by 2.71% as Shares Consolidate Between $0.65 and $0.71TRIN Signal - dars.gov.et
Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power - Stock Titan
Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica - Stock Titan
CALC Q1 2026 Earnings: EPS of $0.30 Crushes Estimates, Stock Advances 6%Revenue Miss Report - vinanet.vn
CALC Q1 2026 Earnings: EPS Swings to Profit With 205.04% SurpriseEarnings Sentiment Score - vinanet.vn
CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com
CalciMedica shares see H.C. Wainwright neutral rating reiterated By Investing.com - Investing.com Canada
Price to book forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
Price to book forward of CalciMedica, Inc. – BOATS:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – NASDAQ:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – BOATS:CALC - TradingView
CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 8K CalciMedica Inc For: 11 August By Investing.com - Investing.com UK
CalciMedica, Inc. 2Q 2026: Net loss $7.7M, EPS $(0.45) — 10-Q Summary - TradingView
CalciMedica (CALC) cuts expenses, raises $15M but flags going concern risk - Stock Titan
CalciMedica Releases Q2 2026 Financial Results - AlphaStreet
CalciMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss - Yahoo Finance
CalciMedica Secures Up To $49 Million Private Placement To Advance Pulmonary Hypertension Pipeline - Minichart
CalciMedica Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CalciMedica Q2 FY26 net loss widens to $7.65 million - Bitget
CalciMedica stock gains 6% despite earnings miss on pulmonary trial By Investing.com - Investing.com South Africa
CalciMedica stock gains 6% despite earnings miss on pulmonary trial - Investing.com
CalciMedica reports Q2 2026 results: $18.6M cash, net loss $7.7M; financing to fund PH programs - TradingView
Calcimedica Inc Azioni (CALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):